Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III randomized trial of the safety and efficacy of three neonatal antiretroviral regimens for prevention of intrapartum HIV-1 transmission.

Trial Profile

Phase III randomized trial of the safety and efficacy of three neonatal antiretroviral regimens for prevention of intrapartum HIV-1 transmission.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Dec 2017

At a glance

  • Drugs Lamivudine (Primary) ; Nelfinavir (Primary) ; Nevirapine (Primary) ; Zidovudine (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 19 Dec 2017 Results assessing drug resistant mutations published in the Clinical Infectious Diseases
    • 27 Jul 2012 Results presented at the 19th International AIDS Conference.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top